MD1003 Aids Walking Speed in Progressive MS, But Carries Risks

MD1003 Aids Walking Speed in Progressive MS, But Carries Risks

302162

MD1003 Aids Walking Speed in Progressive MS, But Carries Risks

High-dose biotin aided walking speed in people with progressive multiple sclerosis after 12 to 15 months as an add-on treatment, an analysis of placebo-controlled clinical trials shows. However, the therapy failed to improve other measures of disability, and was associated with inaccurate lab test results caused by high levels of biotin in the bloodstream — which can lead to complications due to incorrect diagnoses and treatment, the researchers said. The review study, “High-dose biotin for…

You must be logged in to read/download the full post.